Stent Grafts in the Management of Traumatic Tibial Artery Pseudoaneurysms

Traumatic tibial Artery Pseudoaneurysms have historically been treated through highly invasive surgical options. With the advent of newer minimally invasive technologies the challenges of invasive surgery in the peripheral anatomies can be mitigated. Reports on the use of these minimally invasive technologies for the treatment of Traumatic Tibial Artery Pseudoaneurysms can be found in many academic and non academic sources.
One of these reports is the case submitted by Dr. LARINI at the Italian Hospital “OSPEDALE MAGGIORE DI PARMA”, in which a 3.0 x 19 Direct-Stent Stent Graft was used in a 30 year old patient to successfully exclude a pesudoaneurysm obtaining great flow and patency. The patient was admitted with an aneurysm caused by an external tool in a work accident.
It's these amazing cases that excite us. We are pleased to share them with you and hope you will share with others. 

Success @ TCT 2010

Thanks to everyone who joined us at this year's annual TCT congress. We are happy to report a successful turnout of doctors, distributors and other industry professionals. This year we highlighted our Direct-Stent Stent Graft with bold ads in the TCT Daily and graphics in our booth. This generated alot of inquires and interest in the InSitu Stent Graft as well as many of our other products. We look forward to our next visit with many of you at EUROPCR 2011 in 17th - 20th of May.

InSitu on Facebook

We recently launched our InSitu Facebook page. Stay connected and updated with InSitu while you Facebook. To become a fan click here!

InSitu @ SBHCI & SOLACI

As the summer ends so does our trade show season. We recently returned from congresses in Brasil and Argentina. Both shows were successes both on and off the exhibit floor. We introduced some of our new products and met new members of the InSitu family from all over the world.

Our Forte Balloon

We ran across a case study from Endovascular Today reported a 63 year old woman who was treated with a long balloon catheter to accompany cryoplasty for the treatment of a heavily calcified occlusion in the right superficial femoral artery (SFA).

An extra support .018” guidewire was used to reach the lesion and penetrate, with difficulty, halfway through the occlusion. At this time a 4.0mm x 100mm balloon catheter was inserted and tracked to the end of the guidewire. The guidewire and balloon were then advanced through the remainder of the occlusion. The balloon catheter was dilated several times for initial dilation of the 25cm length diseased segment. After dilating the vessel cryoplasty was used to treat the artery.

Follow-up angiography showed positive results with only mild residual stenosis at the previously occluded site. 8 weeks after the procedure the patient had no limitations due to due to claudication.

Typically heavily calcified lesions require a .035” guidewire and support from the guide catheter to cross the lesion. In this case the crossing was successful using only a .018” guidewire and a low profile, tapered tip PTA balloon. In this case ability to proceed with a 0.018” guidewire and PTA balloon catheter was an advantage.

Our Forte Long Balloon catheter is the perfect product for crossing and initial dilation of CTO long lesion occlusions in the superficial femoral artery. The Forte Long Balloon catheter tracks along a .018” guidewire, has a tapered distal tip, and is available in a variety of diameters (4-12mm) and balloon lengths of 100-200mm. Keep this in mind the next time your tackling a difficult lesion and ask your cath lab about Forte Peripheral Long Balloon.

Upcoming InSitu Events

Summer is a busy time of year for us at InSitu. We just finished exhibiting at Europcr in Paris, France, this past May and are preparing for our next three shows. Europcr was a success. We met many new contacts as well as saw many familiar faces.
We begin on July 22nd with the SBHCI congress in Belo Horizonte, Brazil, one of the most important cities of Brazil and known internationally for the Pampulha suburb, which inspired Brasilia. InSitu is proud to exhibit for the first time in this city.
Next we move on to the Solaci Organization's annual congress this August 11th. This year the SOLACI organization and CACI organization of Argentina are joining forces to bring you a unique congress from the heart of Argentina, in beautiful Buenos Aires.
Lastly we end our summer and begin fall with a show in our home country, the United States, heading back to Washington DC on September 25th where will be exhibiting for the seventh time! Our U.S. show gives us a chance to show our appreciation for our loyal customers at our annual TCT distributor event.

Please join us for one of these fabulous shows where the latest advances in current therapies and clinical research will be showcased. We look forward to the next few months and hope we will see you at once of these stops.

Until next time,
hasta la próxima vez,
Até a próxima vez,

The InSitu Team

InSitu Blog Begins

InSitu Technologies Inc would like to introduce you to our latest tool for keeping in touch with our vast network of distributors and physicians around the world, the InSitu Blog. The blog will update you on our products and events, as well as showcase the latest advances in current therapies and clinical research. So check back frequently for updates or click the Follow button on the right hand side of the page to follow us.